January 24, 2017 5:22 PM ET


Company Overview of Iroko Pharmaceuticals, LLC

Company Overview

Iroko Pharmaceuticals, LLC, a specialty pharmaceutical company, develops and commercializes pharmaceutical products. It focuses on treatment options to address patient needs in pain management. The company markets and distributes Indocid (indomethacin) capsules and suppositories; Aldomet (methyldopa) tablets; TIVORBEX (indomethacin) capsules; ZORVOLEX, a nonsteroidal anti-inflammatory drug for the management of osteoarthritis pain and for the treatment of mild to moderate acute pain in adults; and VIVLODEX (meloxicam) capsules, a nonsteroidal anti-inflammatory drug for the management of osteoarthritis pain. It markets and sells its products through distribution and sales network in the Unite...

One Kew Place

150 Rouse Boulevard

Philadelphia, PA 19112

United States

Founded in 2007





Key Executives for Iroko Pharmaceuticals, LLC

Chief Executive Officer, President and Director
Founder and Chairman of the Board
Age: 54
Chief Financial Officer and Senior Vice President
Age: 69
Senior Vice President and General Counsel
Age: 49
Senior Vice President of Commercial Operations - Europe & International
Compensation as of Fiscal Year 2016.

Iroko Pharmaceuticals, LLC Key Developments

Iroko Pharmaceuticals LLC Provides Update in Relation to Zorvolex

Iroko Pharmaceuticals LLC provided an update in relation to its novel Zorvolex® Capsules 18 mg and 35 mg. Iroko has been advised that the United States Food and Drug Administration (FDA) has tentatively approved Lupin Pharmaceuticals Inc.'s, Abbreviated New Drug Application (ANDA) for its Diclofenac Capsules, 18 mg and 35 mg to market a generic version of Iroko's, Zorvolex® Capsules 18 mg and 35 mg. Iroko has and will continue to vigorously defend the several patents and regulatory rights that protect Zorvolex®. Zorvolex® has US regulatory market exclusivity for the management of osteoarthritis pain until August 2017. Iroko is committed to defending the IP protecting Zorvolex® to the fullest extent of the law.

Iroko Pharmaceuticals, LLC Presents at Life Sciences Summit 2016, Nov-03-2016 11:00 AM

Iroko Pharmaceuticals, LLC Presents at Life Sciences Summit 2016, Nov-03-2016 11:00 AM. Venue: 10 on the Park at Time Warner Center, 60 Columbus Circle 10th Floor, New York, NY 10019, United States. Speakers: Kate de Santis, Vice President of Investor Relations.

Iroko Pharmaceuticals, LLC Announces Executive Changes

Iroko Pharmaceuticals, LLC announced the appointment of Louis J. Vollmer as President and Chief Executive Officer effective July 6, 2016. Mr. Vollmer has been serving as President of Iroko since March 2015 and continues as a member of Iroko's Board of Directors, which he joined in February 2014. He succeeds Osagie Imasogie, Iroko's Founder, as CEO; Mr. Imasogie will remain Iroko's Chairman. Mr. Vollmer will oversee the day-to-day operations and long term strategic planning of Iroko, focusing on maximizing the potential of Iroko's SoluMatrix® franchise brands, expanding the company's global presence and creating and acquiring innovative treatment options for responsible pain management.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

Private Placement
June 29, 2016

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Iroko Pharmaceuticals, LLC, please visit www.iroko.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.